Seminar Detail

Advances in Diagnosis and Treatment of Neuromuscular & Neurodegenerative Disorders: What’s Changed in 2016?

Monday, September 26, 2016 at 8:00 AM - 3:30 PM

This event is not currently available for purchase.

For more information: Call (800) 844-8260
Course Description
  • Multiple Sclerosis
  • Parkinson's Disease & Chameleons
  • Myasthenia Gravis vs. Lambert-Eaton Myasthenic Syndrome
  • Muscular Dystrophy
  • Guillain-Barré Syndrome
  • Chronic Inflammatory Demyelinating Polyneuropathy / Polyradiculopathy
  • Amyotrophic Lateral Sclerosis / Motor Neuron Disease

These disorders remain the nation's leading causes of disability. They are devastating and costly. Due to the aging population, the incidence of these disorders is increasing rapidly.

There is a need to provide early diagnosis and apply effective therapies for these disorders. Join expert, Dr. Susan Fralick-Ball, to learn new strategies for the pathophysiologic changes, clinical manifestations, and diagnostic studies for each of these disorders. Gain information on the latest innovative drugs that are geared to slow or stop the disorder progression. Through an engaging presentation style and enlightening case studies, Dr. Fralick-Ball will enhance your knowledge regarding current practice issues. The evidence-based content will improve outcomes for your patients with neuromuscular and neurodegenerative disorders.
Please refer to the course brochure for continuing education information.
Learner Objectives:

  • Specify the preeminent medication management for multiple sclerosis and its complications
  • Examine the most recent diagnostic indicators for multiple sclerosis
  • Summarize your knowledge of Parkinson's disease and its variants
  • Describe common side effects to Parkinson's medications
  • Analyze the pros and cons of medications vs. hands-on treatment for these diseases
  • Outline the differences in myasthenic and cholinergic crisis
  • Explain the long-term care for muscular dystrophies
  • Interpret the syndrome variants for the patient with Guillain-Barré and CIDP
  • Summarize the symptom management for the patient with Amyotrophic Lateral Sclerosis
  • Identify newly found genomic markers for diagnosis and treatment of these disorders


Susan Fralick-Ball is a licensed clinical neuropsychologist with an additional 40 years of clinical/educational nursing practice in a wide range of specialties. As a neuropsychologist, she has worked with patients having a vast variety of neurological disorders. Susan was responsible for coordinating all clinical and administrative activities for the stroke program of a nationally-renowned neurological-medical rehabilitation hospital, where she also developed a stroke support group for patients, family members, and staff. Additionally, she aided patients with neuromuscular and neurodegenerative disorders such as MS, Guillain-Barré, CIDP, Parkinson's, Myasthenia Gravis, ALS, Spinal cord injuries, TBI, head trauma, and dementias.

As a former member of the Neurocognitive Regional Conference Committee, Susan was instrumental in developing and speaking at conferences to teach medical and health care support staff about neurological challenges and developments. She has also taught neurological nursing and neurophysiology at the graduate level. She has mentored and supervised nurses, social workers, psychologists, and music therapists in the clinical setting. Dr. Fralick-Ball is the founder of the PsychMedEd, where she continues to work with patients challenged by the detrimental psychological effects of neurological disorders, is a clinical neuropsychologist for the VistaMed group in the greater Philadelphia area, and a nationally-recognized nursing/psychology educator and conference presenter. She continues to lend social assistance to those with neurological disorders through her charitable organization, With Thy Grace.

Speaker Disclosures

Financial: Susan Fralick-Ball maintains a private practice. Dr. Fralick-Ball receives a speaking honorarium from PESI, Inc.

Nonfinancial: Susan Fralick-Ball is a regular contributor to Advance for Nurses. Dr. Fralick-Ball is a member of the Neurocognitive Regional Conference Committee.
Credits listed below are for full attendance at the live event only. After attendance has been verified, pre-registered attendees will receive an email from PESI Customer Service with the subject line, “Evaluation and Certificate” within one week. This email will contain a link to complete the seminar evaluation and allow attendees to print, email or download a certificate of completion if in full attendance. For those in partial attendance (arrived late or left early), a letter of attendance is available through that link and an adjusted certificate of completion reflecting partial credit will be issued within 30 days (if your board allows). Please see “live seminar schedule” for full attendance start and end times. NOTE: Boards do not allow credit for breaks or lunch.

If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, or questions on home study credit availability, please contact or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of mental health professionals. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your professions standards.

The planning committee and staff who controlled the content of this activity have no relevant financial relationships to disclose. For speaker disclosures, please see speaker bios.

PESI, Inc. offers continuing education programs and products under the brand names PESI, PESI Healthcare, PESI Rehab and Psychotherapy Networker.

Credit Card Required for online registration | Contact us to redeem Gift Certificates